These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 36224583)

  • 1. Optimizing the implementation of a participant-collected, mail-based SARS-CoV-2 serological survey in university-affiliated populations: lessons learned and practical guidance.
    Cramer EY; Snyder T; Ravenhurst J; Lover AA
    BMC Public Health; 2022 Oct; 22(1):1907. PubMed ID: 36224583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and Implementation of Dried Blood Spot-Based COVID-19 Serological Assays for Epidemiologic Studies.
    Wong MP; Meas MA; Adams C; Hernandez S; Green V; Montoya M; Hirsch BM; Horton M; Quach HL; Quach DL; Shao X; Fedrigo I; Zermeno A; Huffaker J; Montes R; Madden A; Cyrus S; McDowell D; Williamson P; Contestable P; Stone M; Coloma J; Busch MP; Barcellos LF; Harris E
    Microbiol Spectr; 2022 Jun; 10(3):e0247121. PubMed ID: 35612315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serological surveys to estimate cumulative incidence of SARS-CoV-2 infection in adults (Sero-MAss study), Massachusetts, July-August 2020: a mail-based cross-sectional study.
    Snyder T; Ravenhurst J; Cramer EY; Reich NG; Balzer L; Alfandari D; Lover AA
    BMJ Open; 2021 Aug; 11(8):e051157. PubMed ID: 34404716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serological surveys to estimate cumulative incidence of SARS-CoV-2 infection in adults (Sero-MAss study), Massachusetts, July-August 2020: a mail-based cross-sectional study.
    Snyder T; Ravenhurst J; Cramer EY; Reich NG; Balzer LB; Alfandari D; Lover AA
    medRxiv; 2021 May; ():. PubMed ID: 33758898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High seroprevalence for SARS-CoV-2 among household members of essential workers detected using a dried blood spot assay.
    McDade TW; McNally EM; Zelikovich AS; D'Aquila R; Mustanski B; Miller A; Vaught LA; Reiser NL; Bogdanovic E; Fallon KS; Demonbreun AR
    PLoS One; 2020; 15(8):e0237833. PubMed ID: 32797108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From disgusting and complicated to simple and brilliant: Implementation perspectives and lessons learned from users and rejectors of mail-in SARS-CoV-2 gargle tests.
    Röhr F; Uellner F; Deckert A; Anders S; Burk R; Knop M; Brugnara L; Bärnighausen T; Jahn A; McMahon S; Souares A
    Front Public Health; 2022; 10():1024525. PubMed ID: 36684995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Canada's approach to SARS-CoV-2 sero-surveillance: Lessons learned for routine surveillance and future pandemics.
    O'Brien SF; Asamoah-Boaheng M; Grunau B; Krajden M; Buckeridge DL; Goldfarb DM; Anderson M; Germain M; Brown P; Stein DR; Kandola K; Tipples G; Awadalla P; Lang A; Behl L; Fitzpatrick T; Drews SJ
    Can J Public Health; 2024 Aug; 115(4):558-566. PubMed ID: 38981961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Multiplex Noninvasive Salivary Antibody Assay for SARS-CoV-2 Infection and Its Application in a Population-Based Survey by Mail.
    Egorov AI; Griffin SM; Fuzawa M; Kobylanski J; Grindstaff R; Padgett W; Simmons S; Hallinger DR; Styles JN; Wickersham L; Sams E; Hudgens E; Wade TJ
    Microbiol Spectr; 2021 Oct; 9(2):e0069321. PubMed ID: 34523986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. At-home self-collection of saliva, oropharyngeal swabs and dried blood spots for SARS-CoV-2 diagnosis and serology: Post-collection acceptability of specimen collection process and patient confidence in specimens.
    Valentine-Graves M; Hall E; Guest JL; Adam E; Valencia R; Shinn K; Hardee I; Sanchez T; Siegler AJ; Sullivan PS
    PLoS One; 2020; 15(8):e0236775. PubMed ID: 32756585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Household transmission of SARS-CoV-2 from unvaccinated asymptomatic and symptomatic household members with confirmed SARS-CoV-2 infection: an antibody-surveillance study.
    Bhatt M; Plint AC; Tang K; Malley R; Huy AP; McGahern C; Dawson J; Pelchat M; Dawson L; Varshney T; Arnold C; Galipeau Y; Austin M; Thampi N; Alnaji F; Langlois MA; Zemek RL
    CMAJ Open; 2022; 10(2):E357-E366. PubMed ID: 35414597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility and lessons learned on remote trial implementation from TestBoston, a fully remote, longitudinal, large-scale COVID-19 surveillance study.
    Naz-McLean S; Kim A; Zimmer A; Laibinis H; Lapan J; Tyman P; Hung J; Kelly C; Nagireddy H; Narayanan-Pandit S; McCarthy M; Ratnaparkhi S; Rutherford H; Patel R; Dryden-Peterson S; Hung DT; Woolley AE; Cosimi LA
    PLoS One; 2022; 17(6):e0269127. PubMed ID: 35657813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring of SARS-CoV-2 antibodies using dried blood spot for at-home collection.
    Miesse PK; Collier BB; Grant RP
    Sci Rep; 2022 Apr; 12(1):5812. PubMed ID: 35388074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of dried blood spots as alternative sampling material for serological detection of anti-SARS-CoV-2 antibodies using established ELISAs.
    Weisser H; Steinhagen K; Höcker R; Borchardt-Lohölter V; Anvari Ö; Kern PM
    Clin Chem Lab Med; 2021 Apr; 59(5):979-985. PubMed ID: 33554537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Staff SARS-CoV-2 Seroprevalence and Mental Health as Key Factors in University Response to COVID-19 Pandemic.
    Lopes DG; Henriques AR; Santos-Dias M; Nunes-da-Silva C; Gonçalves J; de Sousa RD; Abdulghani S; Eletério J; Braga SJ; Soares H; Branco JC; Canhão H; Rodrigues AM
    Front Public Health; 2021; 9():689919. PubMed ID: 34222187
    [No Abstract]   [Full Text] [Related]  

  • 16. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
    Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
    Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns and persistence of SARS-CoV-2 IgG antibodies in Chicago to monitor COVID-19 exposure.
    Demonbreun AR; McDade TW; Pesce L; Vaught LA; Reiser NL; Bogdanovic E; Velez MP; Hsieh RR; Simons LM; Saber R; Ryan DT; Ison MG; Hultquist JF; Wilkins JT; D'Aquila RT; Mustanski B; McNally EM
    JCI Insight; 2021 May; 6(9):. PubMed ID: 33755598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seropositivity of SARS-CoV-2 in an unvaccinated cohort in British Columbia, Canada: a cross-sectional survey with dried blood spot samples.
    Racey CS; Booth A; Albert A; Smith LW; Krajden M; Murray MCM; Côté HCF; Gottschlich A; Goldfarb DM; Sadarangani M; Galea LAM; Kaida A; Brotto LA; Ogilvie GS
    BMJ Open; 2022 Aug; 12(8):e062567. PubMed ID: 36038173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of Commercial SARS-CoV-2 Immunoassays in a Nigerian Population.
    Ige F; Hamada Y; Steinhardt L; Iriemenam NC; Uwandu M; Greby SM; Aniedobe M; Salako BL; Rangaka MX; Abubakar I; Audu R
    Microbiol Spectr; 2021 Oct; 9(2):e0068021. PubMed ID: 34612691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of Newborn Dried Blood Spots to Ascertain Seroprevalence of SARS-CoV-2 Antibodies Among Individuals Giving Birth in New York State, November 2019 to November 2021.
    Damjanovic A; Styer LM; Nemeth K; Yauney E; Rock JM; Bievenue R; Hoen R; Ehrbar D; Kay DM; Caggana M; Parker MM
    JAMA Netw Open; 2022 Aug; 5(8):e2227995. PubMed ID: 35994287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.